Autocomp
510(k) K911340
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK911340 | Date26 Aug 1991 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- KPQ
- Device Class
- Class II
- Regulation
- 21 CFR Part 892.5840
- Advisory Committee
- Radiology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
The Autocomp is a System, Simulation, Radiation Therapy Device designed for use in radiology. It is intended to assist in the precise delivery and verification of radiation therapy by simulating treatment planning and dose calculations, ensuring accurate patient-specific dose distributions.
This device is supplied as a reusable system and is regulated under FDA 510(k) clearance (K911340), classified as a Class II medical device. It operates in radiology settings and adheres to regulatory standards for radiation therapy simulation systems, with no specific sterility requirements noted in the data. The device is authorized for use in the United States and is governed by FDA guidelines for radiation therapy equipment.
Other devices from Victoreen, Inc.
Questions
AI-generated answers, 19 Sep 2026
What is the primary purpose of the Autocomp in a radiology setting?
The Autocomp is designed to assist radiology teams in delivering precise radiation therapy by simulating treatment planning and performing dose calculations. This helps ensure accurate, patient-specific dose distributions, improving the reliability of radiation treatment delivery.
Is the Autocomp intended for single-use or reusable applications?
The Autocomp is supplied as a reusable system, meaning it is built for repeated use in clinical settings rather than disposable after a single application. This aligns with its classification as a Class II medical device under FDA guidelines.
What regulatory pathway does the Autocomp follow, and where is it authorized for use?
The Autocomp is authorized for use in the United States through FDA clearance via a 510(k) submission (K911340), classified as a Class II device. It adheres to FDA standards for radiation therapy simulation systems and is governed by regulatory requirements specific to radiology equipment.
Does the Autocomp require sterilization before use, and if so, what are the guidelines?
The Autocomp is not described as requiring sterility in its specifications, as it is a reusable system designed for use in controlled radiology environments rather than direct patient contact. However, standard infection control practices should still be followed during maintenance and cleaning.
How is the Autocomp categorized in terms of medical specialty and device classification?
The Autocomp is classified under Radiology as its medical specialty and falls under OpenFDA device classification 2 (Class II). It is specifically listed under the product code KPQ, which corresponds to radiation therapy simulation systems, ensuring it meets regulatory standards for that category.